SIRT6 and neoplasm: Since the deacetylase activity of SIRT6 is not required for maintaining telomere dynamics and tumor cells generally encounter increased oxidative stress, our study also suggests the possibility of inhibiting telomere lengthening and cellular proliferation in tumors by targeting SIRT6 at telomeres but not its deacetylase activity.